Senseer LLC is focused on improving healthcare by developing smart microsensing catheter technologies for remote patient monitoring to guide evidence-based treatment. Although the firm is currently focused on the hydrocephalus market, it aims to target other markets, such as the cardiac or urinary ones. The consequence of catheter malfunction and a high shunt failure rate has been that patients suffer many unnecessary, costly medical procedures. Senseer's goal is to increase patients' welfare by enabling remote, real-time monitoring of shunt/catheter status. The firm's MEMS-based, multi-sensor technology allows catheter status to be monitored remotely and noninvasively, providing doctors an inexpensive, rapid and accurate tool for early detection of device performance deviation from patient-specific baselines.
